Gordon Haskett Downgrades Citi Trends to Accumulate, Lowers Price Target to $60
Gordon Haskett analyst Chuck Grom downgrades Citi Trends (NASDAQ:CTRN) from Buy to Accumulate and lowers the price target from $90 to $60.
60 Biggest Movers From Yesterday
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) shares surged 57.1% to close at $5.39 on Monday.
Mid-Afternoon Market Update: Dow Tumbles 250 Points; Zynga Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.70% to 35,978 while the NASDAQ fell 0.93% to 14,796.51. The S&P also fell, dropping, 0.72% to 4,643.29.
Mid-Day Market Update: Nasdaq Dips 300 Points; Apria Shares Surge
Midway through trading Monday, the Dow traded down 1.23% to 35,787.07 while the NASDAQ fell 2.07% to 14,627.21. The S&P also fell, dropping, 1.52% to 4,605.95.
45 Stocks Moving In Monday’s Mid-Day Session
Gainers
Bone Biologics Corporation (NASDAQ: BBLG) shares climbed 71.5% to $5.88.
10 Consumer Discretionary Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Craig-Hallum Maintains Buy on Citi Trends, Raises Price Target to $175
Craig-Hallum analyst Jeremy Hamblin maintains Citi Trends (NASDAQ:CTRN) with a Buy and raises the price target from $165 to $175.